Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue recipe is a multi-herb traditional Chinese medicine (TCM) formulation developed by Dongfang Hospital of the Beijing University of Chinese Medicine. It is specifically designed for the recovery stage of cerebral infarction in patients exhibiting Qi deficiency and blood stasis syndrome. The recipe is a component of the classic Buyang Huanwu decoction, specifically isolating the 'blood-activating' (Huoxue) agents. Its primary ingredients include Radix Paeoniae Rubra (Chishao), Ligusticum wallichii (Chuanxiong), Angelica sinensis (Danggui), Pheretima (Dilong/earthworm), Flos carthami (Honghua), and Semen persicae (Taoren/peach seed). The formulation aims to improve blood circulation, reduce stasis, and support neurological recovery following a stroke. It has been evaluated in clinical trials to determine the specific therapeutic contributions of blood-activating herbs compared to Qi-tonifying components like Astragalus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huoxue recipe.